PYR/PYL genes were highly expressed in SC vs. NA treatments, while PP2C, HAB, ABFs, and SnRK2 showed higher expression in CF vs. NA, SC vs. NA, and SM vs. NA treatments. The gene discussed is SFRP4; the disease is cystic fibrosis.